机构:[1]Department of Traditional Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.[2]The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.[3]The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.[4]Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.深圳市中医院深圳医学信息中心[5]The Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.广东省中医院
General
Program of National Nature Science Foundation of
China (grant no. 81673842) and the General
Program of Natural Science Foundation of
Guangdong Province (grant no.
2019A1515011745 and no. 2021A1515110727)
第一作者机构:[1]Department of Traditional Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
共同第一作者:
通讯作者:
通讯机构:[3]The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.[4]Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
推荐引用方式(GB/T 7714):
Wang Yongfu,Ke Wei,Gan Jianfeng,et al.MicroRNA-29b-3p promotes intestinal permeability in IBS-D via targeting TRAF3 to regulate the NF-κB-MLCK signaling pathway[J].PLOS ONE.2023,18(7):doi:10.1371/journal.pone.0287597.
APA:
Wang Yongfu,Ke Wei,Gan Jianfeng,Zhu He,Xie Xiangyu...&Tang Hongmei.(2023).MicroRNA-29b-3p promotes intestinal permeability in IBS-D via targeting TRAF3 to regulate the NF-κB-MLCK signaling pathway.PLOS ONE,18,(7)
MLA:
Wang Yongfu,et al."MicroRNA-29b-3p promotes intestinal permeability in IBS-D via targeting TRAF3 to regulate the NF-κB-MLCK signaling pathway".PLOS ONE 18..7(2023)